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The cell-surface component  identified by the Lyb-2 system of alloantigens (1-5)  is 
confined to B cells (1, 4). Antibody-secreting B cells, however, are Lyb-2- (6). Thus if 
the exclusive expression of Lyb-2 on B cells implies a  relation to B cell function, then 
Lyb-2  presumably  participates  in  the  generative  phase  of the  antibody  response. 
Evidence to that effect is given in this report. 
Materials  and  Methods 
Mice.  Mice 6-10  wk of age were obtained  from  colonies maintained by E.  A.  Boyse at 
Memorial Sloan-Kettering Cancer Center, New York, and were matched for sex and  age in 
each experiment. 
Antigens.  Sheep erythrocytes (SRBC) 1 were purchased from Colorado Serum Co., Denver, 
Colo. and GIBCO Diagnostics, Madison, Wis. Trinitrophenyl (TNP)-Ficoll (TNPg.~-FicolI) and 
TNP-Brucella abortus were kindly provided by Dr. James Mond and Dr. William Paul of the 
National Institutes of Health, Bethesda, Md. 
Monoclonal Lyb-2.1 Antibody.  For the production of monoclonal Lyb-2.1 antibody (mc-a-Lyb- 
2.1),  spleen cells from BALB/c mice (Lyb-2.2) immunized with DBA/2 spleen cells (Lyb-2.1) 
were fused with P3/NSI/I-Ag4-1 according to the method of K6hler and Milstein (7), yielding 
a clone (9-6.1)  producing antibody against Lyb-2.1. Specificity for Lyb-2.1  was established by 
strain distribution, including the critical distinction of B6 (Lyb-2.2) from the congenic B6-Lyb- 
2.1  strain  which  was  derived  by  typing with  conventional  Lyb-2.1  antiserum.  Absorption 
analysis, indicative of restriction to B cells, also conformed to findings with conventional Lyb- 
2.1 antiserum (1). The titer of mc-a-Lyb-2.1, from ascites of BALB/c mice bearing 9-6.1  cells, 
was  1:20,000  in cytotoxicity assay with Lyb-2.1 spleen cells, and  the maximal proportion of 
lysed spleen cells was 55-60%. 
Immunoselection 
ELIMINATION OF Lyb-2  + CELLS.  Equal volumes of a suspension of spleen cells were centri- 
fuged and resuspended (3 ×  107/ml)  in mc-a-Lyb-2.1 (1:30)  (part  1) or normal mouse serum 
(NMS) (1:40, control) (part 2) for 30 min on ice; the cells were then spun down and resuspended 
in pre-selected rabbit serum (source of complement [C], 1:7) for 30 min at 37°C. The cycle was 
then  repeated, and  the cells washed twice. The concentration of the NMS-control cells was 
then adjusted to 1 ×  107/ml  in MishelI-Dutton medium (MDM), and the Lyb-2-depleted cells 
were suspended in the same volume of MDM. Counts of viable cells (trypan blue exclusion) 
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were recorded for both suspensions, the deficiency caused by Lyb-2 depletion was 55-60%, in 
accord with published data (1, 4). 
ELIMINATION  OF Lyt-2  + AND Thy- 1  + CELLS.  Lyt-2  + cells were eliminated from nylon-purified 
splenic T  cells by one  cycle of treatment  as  above,  with  a  standard  conventional  Lyt-2.2 
antiserum plus C  (1:9)  and cell counts were adjusted as above. The same procedure was used 
when eliminating Thy- 1  + cells with monoclonal Thy- 1.2 antibody (mc-a-Thy-  1.2) (1 : 1,000). 
Mishell-Dutton Culture.  Spleen cells (1 ×  107/ml) were cultured in RPMI- 1640 (Grand Island 
Biological Co., Grand Island, N. Y.) containing 10% fetal bovine serum (FBS) (Microbiological 
Associates, Walkersville, Md.), L-glutamine (2 mM), streptomycin (100 #g/ml), penicillin (100 
U/ml), 2-mercaptoethanol (5 X 10  -5 M), sodium pyruvate (1 mM), and Hepes buffer (10 mM), 
in 16-mm flat-bottomed plates (76-033-65;  Linbro Chemical Co., Hamdem, Conn.) with SRBC 
(5 X  106), TNP-B. abortus (1:1,000 of stock) or TNP-Ficoll (1  ng/ml), with or without me-a- 
Lyb-2. i (1:50 unless otherwise stated), at 37°C in a humidified atmosphere of 10% CO2 without 
rocking. Cultures were fed daily with a mixture of 60 g.I nutritional cocktail (8) and 30 #1 FBS. 
Plaque-forming Cell (PFC) Assay.  PFC  counts  were  determined  on  day  5  for anti-SRBC 
(unless otherwise  stated),  and  on  day  4  for  anti-TNP  response to  T-independent  antigen, 
respectively, by the slide modification (9) of the Jerne plaque assay. TNP was coupled to SRBC 
as described (10).  Results were expressed as PFC per culture or as the percent PFC response: 
=  100 [(PFC experiment)/(PFC control)]. 
Results and  Discussion 
Inhibition  of Generation of Anti-SRBC PFC by Lyb-2 Antibody.  Fig.  1 shows  the  PFC 
responses of cultures in which mc-c~-Lyb-2.1 was included throughout the 5-d culture 
period.  PFC  counts  were  reduced  in  proportion  to  the  concentration  of  Lyb-2.1 
antibody, the greatest reduction,  73%, occurring at the highest concentration of mc- 
ot-Lyb-2.1 tested, 1:50. Specificity for Lyb-2 is shown by the controls in which Lyb-2.1 
antibody caused  no  reduction  in  PFC  counts  when  B6  spleen  cells  (Lyb-2.2)  were 
substituted for congenic B6-Lyb-2.1 spleen cells (Fig.  1). 
Rate of PFC Generation in the Presence of Lyb-2 Antibody.  Might the lower PFC counts 
at  day  5  (Fig.  1)  be  a  result  of a  change  in  rate  of PFC  generation,  the  response 
having peaked earlier or later than day 5 in the presence of Lyb-2 antibody? 
Fig. 2 shows that this is not so. In the range of 1-7 d, PFC counts were maximal at 
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FxG.  I.  Inhibition of generation ofanti-SRBC PFC by Lyb-2 antibody.  10 X l0  n B6-Lyb-2.1 or B6 
(control) spleen cells were cultured with 5 X 10  n SRBC in the presence of mc-a-Lyb-2.1 throughout 
the euhure period. Anti-SRBC PFC were assayed on day 5. Control PFC counts (antibody omitted) 
were 1,543 zl: 233 for B6 and 1,618 4- 189 for B6-Lyb-2.1 (standard  100% response for calculation of 
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FIG.  2.  Rate of anti-SRBC  PFC generation in the presence of Lyb-2 antibody. Spleen cells from 
B6-Lyb-2.1  mice were cultured with 5 X  10  6 SRBC in the presence (0) or absence (C)) of mc-a-Lyb- 
2.1  (1:50). PFC were assayed on days 1-7. The response of control B6 cells (Lyb-2.2) was unaffected 
by the presence of mc-a-Lyb-2.1 (data not shown). 
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Fro.  3.  Effects of Lyb-2 antibody added at  increasing intervals after initiation of culture, mc-a- 
Lyb-2.1  (1:50) was added on days 1-4. Data expressed as in Fig.  1. 
day 5  in the presence and absence of mc-a-Lyb-2. I, implying that  Lyb-2 antibody 
does not alter the rate of generation of antibody-forming cells (AFC). 
Period of Action of Lyb-2 Antibody.  Fig.  3 shows that mc-a-Lyb-2.1 was about one- 
half as effective in reducing PFC counts when  introduced after 24 h  of culture, as 
compared with the first  12 h, and was ineffective after 3 d. 
Non-T Identity of Cells Affected by Lyb-2 Antibody.  Table  I  is  concerned with  the 
possibility that the cells on which Lyb-2 antibody acts, in lowering PFC generation, 
are not in fact B cells, but other cells whose Lyb-2  + phenotype has previously escaped 
serological detection. This question was approached first with cultures composed of 
B6 or B6-Lyb-2.1 splenic T  cells (nylon purified) combined with B6-Lyb-2.1 or B6 T- 
depleted  spleen  cells  (mc-a-Thy-l.2  +  C).  Table  I  shows  that  PFC  counts  were 
reduced by me-a-Lyb-2.1 only when T-depleted spleen cells were Lyb-2.1, the Lyb-2 
phenotype of the T  cells being irrelevant. Thus the cells on which Lyb-2 antibody 
acts are not T  cells. 
Evidence against the Involvement of Suppression.  The data above suggest  that  B  cell 
precursors of AFC  are inhibited by Lyb-2 antibody. Alternatively, Lyb-2 antibody 
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TABLE  I 
Non- T Identity of Cells Affected by Lyb-2 Antibody 
Composition of culture 
T-depleted spleen 
cells 
(8 x  lo ~) 
Nylon-purified splenic T 
cells 
Anti-SRBC PFC per culture 
With me-a-  Without mc-a- 
Lyb-2.1  Lyb-2.1 
(A)  (B) 
Percent re- 
sponse 
(100 A/B) 
B6-Lyb-2.1 
B6-Lyb-2.1 
B6-Lyb- 2.1 
B6 
B6 
B6 
B6 (2 X 10s)  * 
B6 (1 X 106) 
B6 (2 x  10  °) 
B6~Lyb-2.1 (2 ×  10  ~) 
B6-Lyb-2.1  (1 ×  10  n) 
B6-Lyb-2.1  (2 ×  10  s) 
466± 33  1,523 ±  62  31 
406 ±  23  1,137 ±  98  36 
<50 
0 
1,855 ±  I67  2, I90±  107  85 
1,257 ±  134  1,277 ±  85  98 
<3O 
0 
* Number of cells is in parenthesis. 
TABLE  II 
Generation of PFC in Cultures Deprived of Lyt-2 + Cells 
Anti-SRBC PFC per culture 
Percent response 
T cells added*  With mc-a-Lyb-2.1  Without mc-a-Lyb-  (100 A/B) 
2.1 
(A)  (B) 
Unselected ~2 X l0  s  226±89  2,494±350  9 
l1X  10  n  858 ±  82  3,571 ±  163  24 
2 ×  106~  878 ±  125  3,804 ±  584  23 
Lyl  1 ×  10s~  585 ±  163  4,478 ± 460  13 
* B6-Lyb-2.1  nylon-purified T  cells were added  to 8  ×  10  6  T-depleted B6-Lyb-2.1  spleen 
cells.  (Control  PFC counts were  13 ±  2 for T  cells alone and  140 ±  41  for T-depleted 
spleen cells alone.) 
:1: Counts before selection  with anti-Lyt-2.2  plus C.  (Thus the numbers of Lyl cells in the 
unselected  groups are the same as in the Lyl selected groups;  see Materials and Methods.) 
against such a  mechanism, because elimination of Lyt-2 + cells (removing not only the 
Ly23 T  set to which T  suppressors  belong but  also the antecedent  Ly123 set)  did not 
abolish reduction of PFC by Lyb-2 antibody.  Full reduction occurred with no T  cells 
other than  the Lyl  set. 
The  data  in  Fig.  4  substantially  eliminate  the  further  possibility  that  Lyb-2 
antibody  evokes  B  cell-mediated  suppression:  In  this  experiment,  assays  were  con- 
ducted with unselected B6 and B6-Lyb-2.1 spleen cells combined in serial proportions. 
The  reduction  in  PFC  counts  caused  by  mc-a-Lyb-2.1  was  directly  proportional  to 
the number  of B6-Lyb-2.1  cells present, a  result that does not fit the idea of a  released 
B  cell product  inducing suppression. 
Generation of PFC  from  Lyb-2 Heterozygous Cells in the Presence of Lyb-2 Antibody.  One 
might argue that a  reduction in PFC counts can be caused by attachment  of antibody 
per se during  the generation  of PFC.  The experiment  illustrated  in Table  III speaks 
against  this,  for mc-a-Lyb-2.1  caused  no reduction  in  PFC  generated  from  Lyb-2.1/ 
Lyb-2.2  heterozygotes.  This  result  may  also  imply  that  PFC  reduction  depends  on 
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FIG. 4.  Evidence  against  B  cell-mediated  suppression.  B6  and  B6-Lyb-2.1 spleen  cells were 
combined  in the proportions indicated (abscissa) and cultured with SRBC in the presence of mc- 
a-Lyb-2.1 (1:50) as before. Data expressed as in Fig. I (percent PFC response in the absence ofmc- 
a-Lyb-2.1). 
TAnLE  III 
Generation of PFC  from Lyb-2 Heterozygous Cells in the Presence of Lyb-2 Antibody 
Donor of unselected  Lyb-2  Experiment 
spleen cells  phenotype 
Percent response* with 
mc-a-Lyb-2.1 
1:50  1:100 
B6  2/2  1  116  107 
fl  17  9  DBA/2  1/1  ~,]  24  13  t/ 
93  88  (DBA/2 X B6)F1  1/2  ~,~  94  106  LK 
* Calculated as for Table I. 
PFC Response to T-independent Antigen  in the Presence of Lyb-2 Antibody.  The following 
results concern responses to T-independent antigens. Choice of the two antigens TNP- 
B. abortus and TNP-Ficoll was based on evidence that they represent two categories of 
T-independent antigen, the former elicits a normal response in mutant B cell-deficient 
CBA/N  mice and the latter does not  (11). Table IV signifies that  mc-a-Lyb-2.1 did 
not impede the generation of PFC to either antigen. Because T-independent antigens 
can  be  potent  stimulators of B  cell differentiation, further  cultures were set  up,  as 
above, and fed 20 #1 of mc-a-Lyb-2.1 daily to ensure a continuous sufficiency of Lyb- 
2 antibody to react with Lyb-2  + cells that might be recruited from Lyb-2- precursors 
during the culture period; but once again there was no inhibition of the PFC response 
(data not shown). 
PFC Responses of Lyb-2-depleted  Spleen Cells.  It remains to be asked whether the B 
cells  that  generate  PFC  to  T-independent  antigen  and  are  not  affected  by  Lyb-2 
antibody  (Table IV)  are in  fact  Lyb-2  ÷. Table V  answers that  question.  When  the 
responding  population  is  exposed  to  Lyb-2  antibody  and  C,  rather  than  Lyb-2 
antibody  alone  (thus  eliminating Lyb-2  +  cells),  the  PFC  response  to  both  T-inde- 
pendent  and  T-dependent  antigens  is  equally  reduced.  We  infer  that  the  Lyb-2 
molecule is present, but not required, on B cells responding to T-independent antigens. 
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TABLE  IV 
PFC Response to T-independent Antigen in the Presence of Lyb-2 Antibody 
Antigen* 
TNP-B. abortus 
(B6-Lyb-2.1) 
Concentra-  Experiment 1  Experiment 2 
tion of 
mc-a-Lyb-2.1  Anti-TNP-PFC  Percent  Anti-TNP-PFC  Percent 
response  response 
1:50  4,675 +  99  198  3.451 4- 468  127 
1:100  2,445 ±  158  104  2,347 4- 189  87 
1:200  2,008 ±  142  85  Not done 
1:400  2,341 ±  284  99  Not done 
None  2,361 ±  151  100  2,727 ±  77  100 
1:50  2,593 +  108  129  1,150 4- 91  92 
~1:100  2,507 ±  157  125  1,097  ±  114  88 
TNP-Fieoll  ]1:200  2,507 ±  170  125  1,250 ±  24  100 
(DBA/2)  |1:400  2,347 ±  209  117  1,550 4- 94  124 
tNone  2,005 ±  106  100  1,250 ±  92  100 
10 ×  10  s unselected spleen cells were cultured with TNP-B. abortus or TNP-FieolI. 
* Spleen donor is in parenthesis. 
TABLE  V 
PFC Responses of Lyb-2-depleted Spleen Cells 
Antigen  Mouse strain  Percent response* 
SRBC  B6-Lyb-2.1  31 
B6  92 
TNP-B. abortus  B6-Lyb-2.1  48 
B6  109 
TNP-Ficoll  B6-Lyb-2.1  41 
B6  96 
* Percent response =  100 A/B, where A  is the PFC count for cells pretreated 
twice with Lyb-2.l antibody plus C, and B is the control count: NMS plus 
C  substituted for antibody plus C. 
to T-dependent antigen. Whether it is involved in the process of antigen recognition 
or in subsequent events, notably, perhaps, in differentiation induced by receipt of a 
signal from Ly 1 cells, remains to be seen. With regard to possible action of a-Lyb-2 
on accessory cells, this is unlikely for macrophages generally, because the macrophage 
population as a whole does not express Lyb-2; nevertheless the possibility that anti- 
Lyb-2  might  react  with  a  minor  accessory  Lyb-2  +  population  that  has  escaped 
serological recognition is presently being studied by functional assay. In any event, 
Lyb-2 need not necessarily be envisaged as itself the receptor, for it might be part of 
a receptor molecular complex small enough to be obstructed by Lyb-2 antibody. 
Summary 
The  Lyb-2  cell-surface  alloantigens  of the  mouse  are  selectively  and  perhaps 
exclusively expressed in the B lymphocyte lineage, but not on antibody-forming cells. 
Thus if the Lyb-2 molecule is concerned in specific B cell function, it must participate 
in the generative phase of the antibody response. 
Accordingly, monoclonal Lyb-2 antibody was found to depress the plaque-forming 
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within  the  first  3  d  of culture,  but  not  later.  The rate  of PFC  generation was not 
affected, signifying an absolute reduction in the number of PFC generated. Because 
reduction of PFC counts by Lyb-2 antibody was not affected by exclusion of Lyt-2  + 
T  cells, it is unlikely that the reduction depends on augmented suppression by T cells. 
Augmented B cell-mediated suppression is also unlikely, because the PFC response of 
serial combinations of congenic Lyb-2.1 and Lyb-2.2 cells,  in the presence of mono- 
clonal Lyb-2.1 antibody, was reduced only in direct proportion to the number of Lyb- 
2.1  cells present.  The PFC response of Lyb-2.1/Lyb-2.2 heterozygous cells was not 
reduced by Lyb-2.1 antibody, presumably because generation of PFC is impeded only 
if most Lyb-2 sites are blocked. Further evidence that the molecule identified by Lyb- 
2 plays a critical role in the generation of antibody-forming cells  (AFC) in response to 
T-dependent antigen comes from the  finding that  Lyb-2 antibody does not reduce 
the  PFC response to the T-independent  antigens trinitrophenylated  (TNP)  Brucella 
abortus  and  TNP-FicolI,  although  elimination  of  Lyb-2  +  cells  from  the  starting 
population  by  Lyb-2  antibody and  complement  reduces  the  PFC  response  to  T- 
dependent and T-independent antigens alike. 
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